Legal final arguments in Vioxx trial (Reuters)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20051031/hl_nm/merck_vioxx_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/ap/20051026/capt.wxs10910262211.vioxx_litigation_wxs109.jpg?x=130&y=100&sig=JxiZgnITyfEyYUEp8Pfdew--" align="left" height="100" width="130" alt="Defense attorney Diane Sullivan is seen during court proceedings in Atlantic City, N.J., Wednesday, Oct. 26, 2005. Sullivan is representing pharmaceutical giant Merck & Co. in a product liability trial over the withdrawn painkiller Vioxx. (AP Photo/Mary Godleski, Pool)" border="0" /></a>Reuters - Lawyers were set to deliver
closing arguments on Monday in the second trial over Merck & Co
Inc.'s painkiller Vioxx, a case seen as key in determining the
future of thousands of other pending lawsuits filed by users of
the drug.</p><br clear=all>